Analytical Solutions For MRNA Vaccines And Therapeutics

Released: Oct 26, 2023 |

Length: 16 pages |

Language: French |

Resource: Livre Blanc

Messenger RNA (mRNA) therapy enables the body to make the proteins we need to prevent, treat, or cure diseases.

Unlike traditional biologics, mRNAs are large and delicate molecules that are produced using in vitro transcription (IVT), which need to be protected by lipid nanoparticles (LNPs) before they reach target cells.

Analytical characterization of mRNA therapeutics presents unique challenges that require new technologies and solutions.

Work email *

First Name *

Last Name *

Job Title *

Company Name *

Phone *

Address Line 1 *

City *

Zip/Postcode *

Country *

Industry *

Company Size *

Would you be interested in learning more about our content and workflows offered by Thermo Fisher Scientific for analysis of oligonucleotide therapeutics? *

Would you like to receive email updates from The Analytical Scientist and its sponsors? *

Under European law, Thermo Fisher Scientific is required to obtain your consent before sending you email. Will you give Thermo Fisher Scientific consent to send you email, respecting your right to unsubscribe at any time?

We will send you the file via email. May we also send information on other products and services that may interest you? You can opt out at any time.

Please agree to the conditions